129 related articles for article (PubMed ID: 36990729)
1. [Refractory esophageal stricture of esophageal mucous membrane pemphigoid after allogeneic hematopoietic stem cell transplantation].
Fujita N; Yamashita T; Abe F; Nara M; Yoshioka T; Koga H; Ishii N; Takahashi N
Rinsho Ketsueki; 2023; 64(2):107-112. PubMed ID: 36990729
[TBL] [Abstract][Full Text] [Related]
2. A Case of Anti-BP180-type Mucous Membrane Pemphigoid with IgG and IgA Autoantibodies Showing Distinct Reactivities.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Nakazawa M; Sawamura D
Acta Dermatovenerol Croat; 2022 Jul; 30(1):54-56. PubMed ID: 36153720
[TBL] [Abstract][Full Text] [Related]
3. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
4. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis.
Christophoridis S; Büdinger L; Borradori L; Hunziker T; Merk HF; Hertl M
Br J Dermatol; 2000 Aug; 143(2):349-55. PubMed ID: 10951144
[TBL] [Abstract][Full Text] [Related]
5. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
[TBL] [Abstract][Full Text] [Related]
6. Case Report: Mucous Membrane Pemphigoid With IgG and IgA Anti-Laminin γ1 Antibodies and IgA Anti-Laminin α5 Antibodies.
Kuang W; Qian H; Zhang Q; Li W; Hashimoto T; Zeng X; Li X
Front Immunol; 2022; 13():903174. PubMed ID: 35720393
[TBL] [Abstract][Full Text] [Related]
7. Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients.
Alexandre M; Bohelay G; Gille T; Le Roux-Villet C; Soued I; Morin F; Caux F; Grootenboer-Mignot S; Prost-Squarcioni C
Front Immunol; 2022; 13():874108. PubMed ID: 35514989
[TBL] [Abstract][Full Text] [Related]
8. Fc-binding proteins enhance autoantibody-induced BP180 depletion in pemphigoid.
Iwata H; Kamaguchi M; Ujiie H; Ujiie I; Natsuga K; Nishie W; Shimizu H
J Pathol; 2019 Mar; 247(3):371-380. PubMed ID: 30426510
[TBL] [Abstract][Full Text] [Related]
9. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
[TBL] [Abstract][Full Text] [Related]
10. Cicatricial pemphigoid of the oropharynx after allogeneic stem cell transplantation for relapsed follicular lymphoma.
Aisa Y; Mori T; Nakazato T; Yamazaki R; Yamagami J; Amagai M; Ikeda Y; Okamoto S
Int J Hematol; 2005 Oct; 82(3):266-9. PubMed ID: 16207603
[TBL] [Abstract][Full Text] [Related]
11. Desquamative gingivitis associated with IgG/IgA pemphigoid presents a challenging diagnosis and treatment: a case report.
Sánchez AR; Rogers RS; Kupp LI; Sheridan PJ
J Periodontol; 2004 Dec; 75(12):1714-9. PubMed ID: 15732876
[TBL] [Abstract][Full Text] [Related]
12. Case report: Mucous membrane pemphigoid with complicated autoantibody profile indicating the necessity of comprehensive diagnostic methods and the contribution of IgA autoantibodies.
Liu W; Li H; Jin Y; Cheng L; Shi L; Gao Y; Zhou Z; Feng S; Qian H; Hashimoto T; Li X
Front Immunol; 2023; 14():1149119. PubMed ID: 36969205
[TBL] [Abstract][Full Text] [Related]
13. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180.
Schmidt E; Skrobek C; Kromminga A; Hashimoto T; Messer G; Bröcker EB; Yancey KB; Zillikens D
Br J Dermatol; 2001 Nov; 145(5):778-83. PubMed ID: 11736901
[TBL] [Abstract][Full Text] [Related]
14. Symmetrical Skin Lesions on the Gluteal Region in a Patient with Anti-Laminin-332 Mucous Membrane Pemphigoid.
Maki N; Demitsu T; Nagato H; Okada O; Yoneda K; Hashimoto T; Hasunuma N; Osada I; Manabe M
Acta Dermatovenerol Croat; 2021 Jul; 29(2):105-107. PubMed ID: 34477077
[TBL] [Abstract][Full Text] [Related]
15. Anti-BP180-type mucous membrane pemphigoid: report of two cases.
Wada M; Sato J; Shindoh M; Ujiie H; Natsuga K; Nishie W; Shimizu H; Kitagawa Y
Odontology; 2016 Jan; 104(1):114-8. PubMed ID: 25355555
[TBL] [Abstract][Full Text] [Related]
16. Frequency of IgA antibodies in pemphigus, bullous pemphigoid and mucous membrane pemphigoid.
Cozzani E; Drosera M; Parodi A; Carrozzo M; Gandolfo S; Rebora A
Acta Derm Venereol; 2004; 84(5):381-4. PubMed ID: 15370705
[TBL] [Abstract][Full Text] [Related]
17. Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid.
Smith EP; Taylor TB; Meyer LJ; Zone JJ
J Invest Dermatol; 1993 Oct; 101(4):619-23. PubMed ID: 8409534
[TBL] [Abstract][Full Text] [Related]
18. Analysis of antigens targeted by circulating IgG and IgA antibodies in patients with mucous membrane pemphigoid predominantly affecting the oral cavity.
Carrozzo M; Cozzani E; Broccoletti R; Carbone M; Pentenero M; Arduino P; Parodi A; Gandolfo S
J Periodontol; 2004 Oct; 75(10):1302-8. PubMed ID: 15562906
[TBL] [Abstract][Full Text] [Related]
19. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
[TBL] [Abstract][Full Text] [Related]
20. Multiple and repeated sampling increases the sensitivity of direct immunofluorescence testing for the diagnosis of mucous membrane pemphigoid.
Shimanovich I; Nitz JM; Zillikens D
J Am Acad Dermatol; 2017 Oct; 77(4):700-705.e3. PubMed ID: 28676329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
